Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

835
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
835
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

169
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
169
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

222
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
222

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1α and a phosphate cement scaffold.

Biomaterials·2011
Same author

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Clinical cancer research : an official journal of the American Association for Cancer Research·2011
Same author

Fast and efficient fully 3D PET image reconstruction using sparse system matrix factorization with GPU acceleration.

Physics in medicine and biology·2011
Same author

Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.

PloS one·2011
Same author

Detailed assessment of isotope ratio infrared spectroscopy and isotope ratio mass spectrometry for the stable isotope analysis of plant and soil waters.

Rapid communications in mass spectrometry : RCM·2011
Same author

[Enhancement of osteoblastic differentiation of bone marrow mesenchymal stem cells in rats by sinusoidal electromagnetic fields].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2011

相关实验视频

Updated: Jun 27, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

331

肺部疾病中的RNA修饰.

Weiwei Qian1,2, Lvying Yang3, Tianlong Li4

  • 1Emergency Department of Emergency Medicine Laboratory of Emergency Medicine, West China Hospital, And Disaster Medical, Sichuan University Chengdu Sichuan China.

MedComm
|May 6, 2024
PubMed
概括

在肺部疾病 (PD) 中,RNA表观遗传修饰是关键. 本综述详细介绍了N6甲基化和伪尿素等关键修饰,强调它们作为生物标志物和早期诊断和治疗的治疗点的潜力.

关键词:
RNA修改数据库中的RNA修改数据库.基因组RNA的修改 基因组RNA的改变在RNA修饰的功能上,RNA修饰的功能.肺部疾病 肺部疾病

更多相关视频

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.6K
Protein Transfection of Mouse Lung
04:21

Protein Transfection of Mouse Lung

Published on: May 15, 2013

9.4K

相关实验视频

Last Updated: Jun 27, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

331
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.6K
Protein Transfection of Mouse Lung
04:21

Protein Transfection of Mouse Lung

Published on: May 15, 2013

9.4K

科学领域:

  • 分子生物学分子生物学
  • 肺部医学 肺部医学
  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

  • 肺部疾病 (PD) 代表着全球健康的重大负担,包括慢性阻塞性肺病,肺纤维化,喘,感染和肺癌等疾病.
  • 新出现的证据强调了RNA表观遗传修饰在各种肺部疾病的发病过程中的关键作用.
  • 这些修改影响细胞过程和基因表达,影响疾病的进展.

研究的目的:

  • 审查和总结关键的RNA表观遗传修饰涉及到肺部疾病的发展和进展.
  • 探索管理这些修改的监管机制.
  • 要强调RNA修饰作为生物标志物和肺部疾病的治疗点的潜力.

主要方法:

  • 文献综述和现有关于肺部疾病中RNA表观遗传修饰研究的综合研究.
  • 关键RNA修改的详细概述,包括腺的N6甲基化,腺的N1甲基化,5-甲基酸,伪尿素,7-甲基酸和腺到氨酸的编辑.
  • 讨论涉及这些表观遗传变化的调节途径.

主要成果:

  • 几种RNA表观遗传修饰,包括腺的N6甲基化,腺的N1甲基化,5-甲基,伪尿素,7-甲基和腺对 inosine 编辑,都在肺部疾病的发病过程中发挥关键作用.
  • 这些修改动态调节基因表达和与肺损伤和疾病相关的细胞功能.
  • 了解这些机制可以了解疾病病理学.

结论:

  • RNA表观遗传修饰是肺部疾病发展和进展的关键因素.
  • 这些修改为识别新型诊断生物标志物和肺部疾病的创新治疗策略提供了有前途的途径.
  • 对RNA表观遗传学的进一步研究可能会导致肺部疾病的早期诊断和治疗的进步.